tirzepatide surmount trials once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide Further Cements Weight Loss

#Pharma #Semaglutide #GLP1 #ObesityManagement #PharmaceuticalIndustry MANKIND PHARMA LTD Cipla SUN PHARMA USV PRIVATE LIMITED Zydus Group Torrent Pharmaceuticals Ltd Ajanta Pharma Ltd Lupin MSN Laboratories To view or add a comment, sign in #KnowledgeJiff...# The Next Big Opportunity in Indian Pharma

Identification of a glutathione S -transferase without affinity for glutathione sepharose in human kidney

Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections

However, Wegovy works best when combined with a reduced-calorie diet and increased physical activity